The Renal Biomarkers Market is estimated to be valued at US$ 1,476.2 million in 2021 and is expected to exhibit a CAGR of 8.2% over the forecast period (2023-2030), as highlighted in a new report published by Coherent Market Insights.Market Overview:The Renal Biomarkers Market focuses on the development and commercialization of biomarkers that can be used for the early detection and diagnosis...